These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31561043)

  • 1. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
    Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Molecular Hybrids of
    Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
    ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
    Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
    Choubey PK; Tripathi A; Tripathi MK; Seth A; Shrivastava SK
    Bioorg Chem; 2021 Jun; 111():104922. PubMed ID: 33945941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
    Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
    Choubey PK; Tripathi A; Sharma P; Shrivastava SK
    Bioorg Med Chem; 2020 Nov; 28(22):115721. PubMed ID: 33007563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
    Tripathi PN; Srivastava P; Sharma P; Seth A; Shrivastava SK
    Bioorg Med Chem; 2019 Apr; 27(7):1327-1340. PubMed ID: 30795991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
    Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
    ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.
    Mishra P; Sharma P; Tripathi PN; Gupta SK; Srivastava P; Seth A; Tripathi A; Krishnamurthy S; Shrivastava SK
    Bioorg Chem; 2019 Aug; 89():103025. PubMed ID: 31176239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of Piperazine and
    Waiker DK; Verma A; Akhilesh ; A GT; Singh N; Roy A; Dilnashin H; Tiwari V; Trigun SK; Singh SP; Krishnamurthy S; Lama P; Davisson VJ; Shrivastava SK
    ACS Chem Neurosci; 2023 Jun; 14(11):2217-2242. PubMed ID: 37216500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
    Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.